Aging is complex.

It’s driven by 12 interconnected biological mechanisms.
No single ingredient can meaningfully address all of them.
That’s why formulation & testing matters.

8 yrs of research
7 scientists & MDs
7 whole formulation studies
400+ ingredient studies
2,000+ verified clinicians recommend
3rd party-tested for purity & potency

Why NOVOS Is
Scientifically Different

We pioneered the first formulation designed to address all 12 Hallmarks of Aging simultaneously, with scientific studies at universities around the world.

01

A Systems Approach to Aging

Designed around all 12 Hallmarks of Aging, not a single pathway, ingredient, or trend.

02

The Complete Formula Is Studied

Most supplements rely on research about individual ingredients. NOVOS studies the complete Core formulation people actually take, because ingredients can behave differently when combined.

03

From Mechanisms to Human Trials

Our research spans cellular mechanisms, animal lifespan, epigenetic aging, and randomized, double-blind, placebo-controlled human research.

04

Built With Leading Longevity Scientists

Developed with internationally recognized scientists and physicians working across the biology of aging.

05

Recognized and Trusted Worldwide

Selected by leading longevity organizations and trusted by major hospitals, clinics, and more than 2,000 healthcare professionals.

More good years,
& the science to back it up

Studies conducted by scientists and physicians at universities worldwide have found that NOVOS formulations produce a range of longevity-relevant outcomes.

Cardiovascular health is longevity

Cardiovascular disease is the leading cause of age-related death worldwide, while better cardiovascular health is associated with substantially longer life expectancy. Healthy blood vessels are central to both lifespan and healthspan.

Conducted at
University of Surrey
Conducted by
Christian Heiss, MD
Professor of Cardiovascular Medicine, Associate Head of Medical School

The human trial

In a randomized, double-blind, placebo-controlled trial of healthy adults ages 40 to 65, NOVOS Core demonstrated both immediate and sustained improvements in cardiovascular markers, with effects observed after the first dose and at six months.

NOVOS Core showed greater improvements in cardiovascular health markers than most studied supplements & lifestyle changes

The improvements observed in the study were larger than those reported in several published studies of commonly researched cardiovascular interventions.

Sustained FMD benefit (%)

NOVOS Core2.9
Tea (green/black)2.3
Resistance training2.11
Blueberries2.01
CoQ101.69
Nitric oxide booster1.6
Folic acid1.51
Resveratrol1.4

Based on a comprehensive analysis of comparable published studies across endothelial function, arterial flexibility, and blood pressure. Comparisons were not from head-to-head trials.

Biotech standards applied to natural supplements

Three levels of scientific study

  • In Vitro Mechanisms of Aging
  • Animal Lifespan
  • Human Healthspan & Surrogates of Aging

Study highlights

77%

DNA protection in vitro

Ingredients in NOVOS Core supported DNA integrity by up to 77% in skin cells exposed to irradiation.

In vitro study. Not indicative of human outcomes.

18%

Longer lifespan animal

In aged mice, NOVOS Core extended lifespan by over 18%.

Animal study. Results may not translate to humans.

73%

Aged slower case study

In a 12-participant case study, 73% slowed their biological pace of aging.

Case study, n=12. Individual results may vary.

22%

Firmer skin pilot

In a 6-month pilot, all participants improved skin firmness by an average of 22%.

Pilot study, n=4. Individual results may vary.

Built With World-Class Scientists

Dr. J. Pedro Magalhães
“NOVOS has been using a novel science-based approach for developing its formulation. [They are] a leader in the longevity space.”
Dr. J. Pedro Magalhães, PhD
Harvard Medical School
Dr. George Church
“I see NOVOS as inspiring: they approach aging as a complex phenomenon, aiming at all pathways and Hallmarks of Aging simultaneously.”
Dr. George Church, PhD
Harvard Medical School
Dr. Pamela Maher
“What really impressed me about NOVOS was the comprehensiveness of their analysis of aging research to design their product.”
Dr. Pamela Maher, PhD
Salk Institute
Dr. Oliver Medvedik
“NOVOS Core has been reviewed by scientists within the aging research community to ensure the most effective and safest ingredients.”
Dr. Oliver Medvedik, PhD
Harvard Medical School, The Cooper Union

No Other Longevity Company Comes Close

Feature NOVOS Most others
NOVOS studies the complete formulation rather than assuming that findings from individual ingredients will apply to the finished product, as ingredient-level results often do not translate to the formula as a whole. This allows researchers to evaluate the actual combination, doses, and effects customers receive. Yes Ingredient studies only
NOVOS Core was evaluated in randomized, double-blind, placebo-controlled human clinical research—the gold standard scientific design used to reduce bias and compare outcomes against placebo. Findings are now under peer review. Yes Rarely
The NOVOS research program spans cellular models, animal research, and human clinical research. Each level answers a different question—from biological activity and effects on aging mechanisms, to organism-level lifespan outcomes, to measurable effects on biological systems predictive of healthspan and lifespan in people. Yes Rarely across all three
In a randomized, double-blind, placebo-controlled human trial, the complete NOVOS Core formulation provided nutritional support for biological systems predictive of lifespan and healthspan. The trial included clinically recognized measures of vascular aging and cardiovascular function. Yes Extremely rare
The complete NOVOS Core formulation was evaluated in an animal lifespan study and increased lifespan by more than 18% compared with the control group, the largest percentage increase we identified among studies of aged mice. Animal studies do not demonstrate that the formulation extends human lifespan and are not relied upon to represent health benefits in humans. Yes Almost never
The human trial measured endothelial function, blood-vessel flexibility, and systolic blood pressure already within the normal range. These are objective functional measures of how the cardiovascular system is working, rather than customer surveys, subjective reports, or surrogate blood biomarkers. Yes Often surveys, not measures

Tested, verified,
& transparent.

Every batch is held to the same standard the science demands: independently checked and openly documented.

  • Independently tested by Light Labs Third-party laboratory analysis, separate from NOVOS.
  • Verified on SuppCo Listed and verified on the independent supplement transparency platform.
  • Certificate of Analysis on every batch A documented CoA accompanies each production run.

Recognized across science,
beauty & innovation.

Honored by influential organizations and publications shaping longevity, wellness, skin health, and the future of business.

  • WSJ Future of Everything
  • XPRIZE Top 100 Projects Healthspan Competition
  • Beacon Awards
  • BeautyMatter Future 50
  • Beauty From Within category
  • INNOCOS Wellness & Longevity Choice Awards

Build your longevity routine

Start with comprehensive daily support. Add targeted nutrition, energy, and measurement based on your goals.

Daily Foundation
NOVOS Core
Start here

NOVOS Core

12 Hallmarks One daily drink Human clinical trial

Comprehensive daily support for energy, sleep, focus, and whole-body resilience—targeting all 12 Hallmarks of Aging.

From $2.60/day.Start with Core
Cellular Energy
NOVOS Boost

NOVOS Boost

99% pure NMN NAD+ support Pairs with Core

Targeted support for cellular energy, healthy metabolism, and staying strong as you age.

From $1.05/day.Shop Boost
Whole-Body Support
NOVOS Vital

NOVOS Vital

7 organ systems Daily gummies Clinically studied

Daily support for seven key organ systems, with clinically studied ingredients for cardiovascular and whole-body health.

From $1.63/day.Shop Vital
Longevity Nutrition
NOVOS Bar

NOVOS Bar

15g protein 7g fiber Up to 20 superfoods

Protein, fiber, superfoods, and key longevity nutrients for the days a full meal is hard to get to.

$3.60 per bar with subscription.Shop Bar
Measure How You’re Aging
NOVOS Age

NOVOS Age

One blood sample 4 age metrics Lab-grade

See how you are aging with Biological Age, Pace of Aging, Organ Ages, and Telomere Length—all from one blood sample.

$349 single kit.Shop Age

Questions, answered.

Everything you need to know about NOVOS, the science, and getting started.

What is NOVOS Core?
A once-daily drink with 12 science-backed ingredients, uniquely designed to address all 12 Hallmarks of Aging simultaneously. One sachet mixes into water, juice or a smoothie, in Orange, Tropical Passion or Unflavored.
What makes NOVOS different from other longevity supplements?
Most companies sell supplements. NOVOS studied its finished formula in a randomized, double-blind, placebo-controlled human clinical trial, then built the tools to let you measure your own progress.
Is NOVOS backed by human clinical research?
Yes. NOVOS Core was studied in a randomized, double-blind, placebo-controlled trial at the University of Surrey, where adults 40+ took one serving daily for six months.
How soon might I notice a difference?
Timelines vary from person to person. Some notice steadier energy or sleep in the first weeks, and in a self-reported customer survey 81% of NOVOS customers feel a difference within 2 weeks across areas like skin, energy, mood, cognition, sleep and overall well-being. Changes in aging biology build over time, which is why the clinical study ran for six months. Self-reported. Individual results will vary.
Which NOVOS product should I start with?
Most people start with NOVOS Core as the daily foundation, then add NOVOS Boost or NOVOS Vital depending on their goals. NOVOS Bar is the on-the-go option, with 20+ longevity ingredients and 15 g of protein. NOVOS Age lets you measure where you are and track your progress.
How can I measure my progress?
NOVOS Age measures your Biological Age, Pace of Aging, Organ Ages, and Telomere Length from a single blood sample, so you can track changes over time.

Have more questions? Click here for our FAQ page.

A systems approach to aging

Aging is not one process. NOVOS Core is built to work on many of them at once.

Most supplements target a single pathway. One ingredient, one mechanism, one effect. That approach can work, but it treats aging as though it were a single problem with a single lever.

Aging biology describes something more distributed. Researchers have converged on the 12 Hallmarks of Aging, a set of interconnected processes that includes epigenetic alterations, loss of proteostasis, cellular senescence, mitochondrial dysfunction, genomic instability, deregulated nutrient sensing, and altered intercellular communication.

NOVOS Core is designed to target all 12 Hallmarks of Aging. Ingredients are selected for the aging pathways they act on, and preference goes to those with the potential to influence more than one.

The 12 Hallmarks of Aging

01Genomic instabilityDamage that accumulates in your DNA over time. Healthy DNA repair keeps cells functioning correctly.
02Telomere shorteningTelomeres are the protective caps on chromosomes. Each cell division shortens them slightly, until cells stop dividing.
03Epigenetic alterationsChanges in how genes are turned on or off as we age. Epigenetic clocks estimate biological age by measuring these changes.
04Loss of proteostasisMisfolded proteins accumulate and stop working properly, contributing to age-related dysfunction.
05Disabled macroautophagyAutophagy is the cell’s recycling system. When it slows, damaged components build up inside cells.
06Deregulated nutrient sensingPathways like mTOR and AMPK that tell cells when to grow vs. when to repair lose their balance with age.
07Mitochondrial dysfunctionMitochondria are the cell’s power plants. They become less efficient over time, producing less energy and more oxidative stress.
08Cellular senescenceOld, stressed cells stop dividing but don’t die. Instead they linger and release inflammatory signals.
09Stem cell exhaustionTissues lose the ability to replenish themselves as the stem cell reservoir declines.
10Altered cellular communicationCells communicate via signaling molecules. With age, these signals get noisier and less coordinated.
11InflammagingChronic, low-grade inflammation that accumulates with age and contributes to most age-related conditions.
12Microbiome dysbiosisAn imbalanced gut microbiome influences inflammation, metabolism, and even brain function as we age.

Aging happens on many fronts. A formula built around one of them is answering a narrower question.

Reference: López-Otín et al., “Hallmarks of Aging: An expanding universe” (Cell, 2023).

The complete formula is studied

Most supplements rely on research about individual ingredients. NOVOS studies the complete formulation people actually take.

Ingredient-level evidence answers a narrower question than it appears to. A study showing that a compound works in isolation does not establish that the same compound works the same way inside a finished formula, alongside a dozen others, at the doses a person actually takes. Ingredients can behave differently when combined. That is a testable question, and the way to answer it is to study the formula as it ships.

NOVOS Core was evaluated as a complete formulation in a randomized, double-blind, placebo-controlled human trial. The product studied is the product on the shelf. Findings are preliminary; the manuscript is under peer review.

The gapMost supplement evidence comes from studies of single ingredients, often at different doses and in different populations than the finished product. The formula itself is rarely tested.
The questionCombining ingredients can change how they behave. Whether a specific combination helps, does nothing, or interferes is something that has to be measured rather than assumed.
The answerNOVOS Core was studied as a complete formula in randomized, placebo-controlled human research, not inferred from its parts. It is among the few consumer longevity formulas evaluated this way.
7+ yrsOf research spanning mechanistic studies, animal models, and a human clinical trial
3University studies across cells, animals, and people
1 formulaTested as a whole, at the dose people take

These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. Individual results may vary.

From mechanisms to human trials

Evidence gets harder to produce the closer it gets to people. NOVOS Core has been studied at every level.

Most longevity supplements stop at the first tier: ingredients are selected from published research, and that research becomes the claim. It is the cheapest evidence to obtain and the furthest from the question a customer is actually asking. NOVOS Core has been studied through four tiers, each harder to reach than the last.

Tier 1Ingredient selection & mechanismWhich pathways does each ingredient act on? Ingredients chosen for the aging pathways they target, across all 12 Hallmarks of Aging. Over 950 peer-reviewed studies inform the formulation, including more than 400 on the Hallmarks framework itself.
Tier 2In vitroDoes the formula do anything at the cellular level? Ingredients in NOVOS Core supported DNA integrity by up to 77% in skin cells exposed to irradiation. In vitro study; not indicative of human outcomes.
Tier 3Animal lifespanIs a lifespan effect biologically plausible? In aged mice, NOVOS Core extended lifespan by over 18%, a record for an over-the-counter longevity formulation in aged mice. Conducted at Newcastle University by Prof. von Zglinicki. Animal studies are not relied upon to support representations of health benefit in humans.
Tier 4Human clinical trialDoes it change functional markers in people? A randomized, double-blind, placebo-controlled trial in healthy adults aged 40 to 65, conducted at the University of Surrey by Prof. Christian Heiss, showing differences versus placebo across endothelial function, blood vessel flexibility, and systolic blood pressure already within the normal range. Preliminary; manuscript under peer review.

Cardiovascular function was the first system tested because the cardiovascular system is among the earliest to show measurable change with age, which makes it the most informative place to look first.

Very few companies in this category run any study at all on their finished formula. NOVOS Core has been studied at four levels, including in people.

These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. Individual results may vary.

Built with leading longevity scientists

Developed with internationally recognized scientists and physicians working across the biology of aging.

NOVOS products were formulated in collaboration with researchers from Harvard Medical School, MIT, the Salk Institute, and the National University of Singapore. Their work spans genomics, neurobiology, comparative biology of aging, and clinical medicine.

  • Dr. George Church, PhDHarvard Medical School & MITPublished the first direct genomic sequencing method in 1984 and is known as a father of synthetic biology and personalized genomics. Elected to the National Academy of Sciences and the National Academy of Engineering.
  • Dr. Pamela Maher, PhDSalk Institute for Biological StudiesAmong the first researchers to bring aging into drug discovery for Alzheimer’s. Identified geroneuroprotectors, a class of compounds shown to slow the aging process in mice.
  • Dr. J. Pedro de Magalhães, PhDUniversity of BirminghamLeads the Integrative Genomics of Aging Group and built computational tools and databases for studying aging, including comparative genomics of longevity across species.
  • Dr. Oliver Medvedik, PhDThe Cooper UnionDirector of the Kanbar Center for Biomedical Engineering. Performed his doctoral research in Dr. David Sinclair’s Harvard lab and co-founded the Life Extension Advocacy Foundation.
  • Dr. Avi Rosenbaum, PhDHarvard Medical SchoolDeveloped genome sequencing and interpretation technologies in Prof. George Church’s lab. Built the first academic Next Generation Sequencing platform and holds five patents.
  • Dr. Robert Lufkin, MDUSC School of MedicineChief of Metabolic Imaging and Professor of Radiology, with over 200 peer-reviewed papers and 14 books. Inventor of the globally used Lufkin Needle.
  • Dr. Matt Kaeberlein, PhDUniversity of Washington · ConsultantProfessor of Pathology whose research focuses on the basic mechanisms of aging and interventions that promote healthspan. Has published nearly 200 papers in leading scientific journals.
  • Dr. Kris Verburgh, MDUniversity of Brussels · Singularity University BeneluxMedical doctor specializing in aging and longevity. Wrote four science books by age 28, including The Longevity Code, and has lectured at the European Parliament and Cambridge University.

Recognized and trusted worldwide

Selected by leading longevity organizations and carried by major hospitals and clinics.

Recognition in this category tends to come from marketing budgets. NOVOS Core is stocked by institutions that evaluate what they carry, and recommended by clinicians who have no obligation to.

InstitutionsNOVOS products are carried in leading wellness and medical institutions, including Mayo Clinic Store, Remedy Place, and Extension Health.
RecognitionSelected as an XPRIZE Top 100 project in the $101M Healthspan competition, one of only two supplement companies included.
Practitioners2,000+ verified clinicians recommend NOVOS through FrontRowMD.

It has been a pleasure to watch NOVOS take a disciplined, biology-first approach, combined with a willingness to engage in rigorous evaluation rather than shortcuts, in a space that too often prioritizes hype over evidence.Doina Kulick, M.D. · Lead Physician, Longevity Medicine Program at Mayo Clinic Arizona

Human clinical trial · Systolic blood pressure

Blood pressure, held in the healthy range

Systolic blood pressure is one of the most widely studied markers of cardiovascular aging. In the NOVOS Core trial it was measured over six months, in adults whose readings were already normal at the start.

Placebo-adjusted difference −6.1 mmHg Systolic blood pressure, for blood pressures already within the normal range. Participants remained within the normal range throughout.

Why systolic blood pressure was measured

Blood pressure rises with age in most people, and systolic pressure is among the most established functional markers used in cardiovascular aging research. It is measurable, it changes over time, and it is directly relevant to how the cardiovascular system ages.

Because participants entered the trial already within the normal range, the study asked a harder question than most: can a nutritional formula support healthy blood pressure in people who are already healthy?

  • Randomized
  • Double-blind
  • Placebo-controlled
  • 6 months
NOVOS Core−8.5
Placebo−1.5
Adjusted−6.1

Measured against other studied interventions

Effect sizes reported in separately published clinical trials and meta-analyses of adult populations. Ordered by magnitude.

SBP reduction (mmHg)

NOVOS Core6.1
Soy nuts5.0
Cocoa4.5
Beetroot / nitrate4.4
Flavonoids4.15
Aerobic exercise4.0
HIIT3.9
DASH diet3.9
Vitamin C3.12
Resistance training2.9
Magnesium2.8
Quercetin2.55
Dietary sodium reduction2.4
Severe weight loss2.4
Omega-32.4
Tea2.3
Potassium2.15
Curcumin1.75

These figures come from separately published studies, not from a head-to-head trial. Study populations, durations, and measurement methods differ, so the comparison shows the scale of reported effects rather than a direct contest between interventions.

Every participant started within the normal blood pressure range and stayed within it. The trial measured support for healthy blood pressure, not reduction of high blood pressure.

Read the trial detail

These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. Individual results may vary.

Human clinical trial · Endothelial function

A response from the first dose, still there at six months

Endothelial function describes how well the inner lining of the blood vessels responds and adapts. It is one of the earliest measurable signals in cardiovascular aging, and it was the primary endpoint of the NOVOS Core trial.

Flow-mediated dilation, versus placebo +3.9% / +2.9% at 1 hr / 6 mo Adjusted between-group difference, p<0.0001. Measured by flow-mediated dilation.

Why endothelial function was measured

The endothelium is the single-cell layer lining every blood vessel in the body. Its ability to respond and dilate declines with age, often decades before anything shows up clinically, which is why flow-mediated dilation is one of the most established functional markers in cardiovascular aging research.

What makes this result unusual is the shape of it. A measurable difference appeared within an hour of the first dose, and a difference was still present after six months of daily use. Most nutritional interventions don’t improve endothelial function, and when they do, they show one or the other.

  • Randomized
  • Double-blind
  • Placebo-controlled
  • 6 months
1 hour+3.9%
6 months+2.9%
p-value<0.0001

Reported effect sizes across studied interventions

How much larger the NOVOS Core effect was than effects reported in separately published studies of these interventions.

Relative Effect Size of NOVOS Core vs other interventions

vs omega-3+205%
vs walnuts+176%
vs Mediterranean diet+123%
vs resveratrol+107%
vs folic acid+92%
vs CoQ10+78%
vs blueberries+44%

These figures come from separately published studies, not from a head-to-head trial. Study populations, durations, and measurement methods differ, so the comparison shows the scale of reported effects rather than a direct contest between interventions.

The endothelium is where cardiovascular aging tends to show up first. It is also where a response can be seen soonest.

Read the trial detail

These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. Individual results may vary.

Human clinical trial · Cardiovascular aging

Blood vessels that stayed more flexible

Blood vessels stiffen gradually with age, and pulse wave velocity is the standard way to measure it. In the NOVOS Core trial, the difference at six months was 1.18 m/s versus placebo.

Pulse wave velocity, versus placebo at 6 months 1.18 m/s Adjusted between-group difference. For context, blood vessel flexibility typically declines about 1.0 m/s per decade of aging.

Why blood vessel flexibility was measured

Pulse wave velocity measures how fast a pressure wave travels along a blood vessel. The stiffer the vessel, the faster the wave, which makes it a direct functional readout of cardiovascular aging rather than an indirect one.

The decade figure is the useful anchor here. Blood vessel flexibility declines by roughly 1.0 m/s per decade in adult populations, which gives the 1.18 m/s difference a scale a reader can hold onto.

  • Randomized
  • Double-blind
  • Placebo-controlled
  • 6 months
Difference1.18
Per decade~1.0
Timepoint6 mo

Reported effect sizes across studied interventions

How much larger the NOVOS Core effect was than effects reported in separately published studies of these interventions.

Relative Effect Size of NOVOS Core vs other interventions

vs cocoa flavanols+195%
vs weight loss+154%
vs magnesium+119%
vs aerobic exercise+103%

These figures come from separately published studies, not from a head-to-head trial. Study populations, durations, and measurement methods differ, so the comparison shows the scale of reported effects rather than a direct contest between interventions.

Blood vessel stiffening is one of the more predictable changes of aging. It is also one of the more measurable.

Read the trial detail

These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. Individual results may vary.

Your Cart 0

Your cart is empty

Start your longevity protocol with NOVOS.

Shop NOVOS
Subtotal $0.00

Shipping, taxes & subscription details are calculated at checkout.